Anika Therapeutics(ANIK) - 2023 Q4 - Annual Results

EXHIBIT 99.1 Anika Reports Fourth Quarter and Year-End 2023 Financial Results Revenue growth and adjusted EBITDA exceeded expectations in the fourth quarter and full year OA Pain Management achieved record annual revenues of $102 million, up 11% in 2023 Announces cost reduction initiatives providing annualized savings of approximately $10 million Anika positioned to generate adjusted EBITDA of $25 to $30 million in 2024, up over 75% at the midpoint, representing an adjusted EBITDA margin of at least 15% BED ...